UniProt ID | URP2_HUMAN | |
---|---|---|
UniProt AC | Q86UX7 | |
Protein Name | Fermitin family homolog 3 | |
Gene Name | FERMT3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 667 | |
Subcellular Localization | Cell projection, podosome. Present in the F-actin surrounding ring structure of podosomes, which are specialized adhesion structures of hematopoietic cells.. | |
Protein Description | Plays a central role in cell adhesion in hematopoietic cells. [PubMed: 19234463] | |
Protein Sequence | MAGMKTASGDYIDSSWELRVFVGEEDPEAESVTLRVTGESHIGGVLLKIVEQINRKQDWSDHAIWWEQKRQWLLQTHWTLDKYGILADARLFFGPQHRPVILRLPNRRALRLRASFSQPLFQAVAAICRLLSIRHPEELSLLRAPEKKEKKKKEKEPEEELYDLSKVVLAGGVAPALFRGMPAHFSDSAQTEACYHMLSRPQPPPDPLLLQRLPRPSSLSDKTQLHSRWLDSSRCLMQQGIKAGDALWLRFKYYSFFDLDPKTDPVRLTQLYEQARWDLLLEEIDCTEEEMMVFAALQYHINKLSQSGEVGEPAGTDPGLDDLDVALSNLEVKLEGSAPTDVLDSLTTIPELKDHLRIFRIPRRPRKLTLKGYRQHWVVFKETTLSYYKSQDEAPGDPIQQLNLKGCEVVPDVNVSGQKFCIKLLVPSPEGMSEIYLRCQDEQQYARWMAGCRLASKGRTMADSSYTSEVQAILAFLSLQRTGSGGPGNHPHGPDASAEGLNPYGLVAPRFQRKFKAKQLTPRILEAHQNVAQLSLAEAQLRFIQAWQSLPDFGISYVMVRFKGSRKDEILGIANNRLIRIDLAVGDVVKTWRFSNMRQWNVNWDIRQVAIEFDEHINVAFSCVSASCRIVHEYIGGYIFLSTRERARGEELDEDLFLQLTGGHEAF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Acetylation | ---MAGMKTASGDYI ---CCCCCCCCCCCC | 39.77 | 25953088 | |
5 | Ubiquitination | ---MAGMKTASGDYI ---CCCCCCCCCCCC | 39.77 | - | |
6 | Phosphorylation | --MAGMKTASGDYID --CCCCCCCCCCCCC | 19.70 | 28122231 | |
8 | Phosphorylation | MAGMKTASGDYIDSS CCCCCCCCCCCCCCC | 37.11 | 20058876 | |
11 | Phosphorylation | MKTASGDYIDSSWEL CCCCCCCCCCCCEEE | 15.34 | 21082442 | |
14 | Phosphorylation | ASGDYIDSSWELRVF CCCCCCCCCEEEEEE | 28.00 | 23403867 | |
15 | Phosphorylation | SGDYIDSSWELRVFV CCCCCCCCEEEEEEE | 22.33 | 23403867 | |
31 | Phosphorylation | EEDPEAESVTLRVTG CCCCCCCEEEEEEEC | 27.70 | 28060719 | |
33 | Phosphorylation | DPEAESVTLRVTGES CCCCCEEEEEEECCC | 20.37 | 28060719 | |
42 | Ubiquitination | RVTGESHIGGVLLKI EEECCCCHHHHHHHH | 7.76 | 24816145 | |
56 | Ubiquitination | IVEQINRKQDWSDHA HHHHHHCCCCCCCHH | 48.39 | 29967540 | |
60 | Phosphorylation | INRKQDWSDHAIWWE HHCCCCCCCHHHHHH | 28.01 | 28270605 | |
69 | Ubiquitination | HAIWWEQKRQWLLQT HHHHHHHHHHHHHHH | 34.73 | 29967540 | |
69 | Acetylation | HAIWWEQKRQWLLQT HHHHHHHHHHHHHHH | 34.73 | 26822725 | |
115 | Phosphorylation | RALRLRASFSQPLFQ HHHHHHHHCCHHHHH | 20.99 | 28450419 | |
117 | Phosphorylation | LRLRASFSQPLFQAV HHHHHHCCHHHHHHH | 28.52 | 28450419 | |
132 | Phosphorylation | AAICRLLSIRHPEEL HHHHHHHCCCCHHHH | 23.36 | 26546556 | |
155 | Ubiquitination | KEKKKKEKEPEEELY HHHHHCCCCCHHHHH | 83.73 | - | |
162 | Phosphorylation | KEPEEELYDLSKVVL CCCHHHHHHHHHHHH | 20.37 | 28796482 | |
165 | Phosphorylation | EEELYDLSKVVLAGG HHHHHHHHHHHHHCC | 22.10 | 28796482 | |
166 | Ubiquitination | EELYDLSKVVLAGGV HHHHHHHHHHHHCCH | 43.59 | 29967540 | |
173 | Ubiquitination | KVVLAGGVAPALFRG HHHHHCCHHHHHHCC | 5.88 | 22505724 | |
188 | Phosphorylation | MPAHFSDSAQTEACY CCCCCCCCHHHHHHH | 22.52 | 22210691 | |
191 | Phosphorylation | HFSDSAQTEACYHML CCCCCHHHHHHHHHH | 25.85 | 22210691 | |
195 | Phosphorylation | SAQTEACYHMLSRPQ CHHHHHHHHHHHCCC | 9.41 | 22210691 | |
199 | Phosphorylation | EACYHMLSRPQPPPD HHHHHHHHCCCCCCC | 34.05 | 22210691 | |
217 | Phosphorylation | LQRLPRPSSLSDKTQ HHCCCCCCCCCCCHH | 45.23 | 28450419 | |
218 | Phosphorylation | QRLPRPSSLSDKTQL HCCCCCCCCCCCHHH | 34.28 | 28450419 | |
220 | Phosphorylation | LPRPSSLSDKTQLHS CCCCCCCCCCHHHHH | 38.72 | 28450419 | |
222 | Ubiquitination | RPSSLSDKTQLHSRW CCCCCCCCHHHHHHH | 34.49 | 25015289 | |
235 | Ubiquitination | RWLDSSRCLMQQGIK HHHHHHHHHHHHCCC | 3.92 | 22505724 | |
239 | Ubiquitination | SSRCLMQQGIKAGDA HHHHHHHHCCCCCCE | 41.43 | 22505724 | |
242 | Ubiquitination | CLMQQGIKAGDALWL HHHHHCCCCCCEEEE | 53.81 | - | |
243 | Ubiquitination | LMQQGIKAGDALWLR HHHHCCCCCCEEEEE | 21.12 | 22505724 | |
252 | Ubiquitination | DALWLRFKYYSFFDL CEEEEEEEEEEECCC | 36.52 | - | |
263 | Phosphorylation | FFDLDPKTDPVRLTQ ECCCCCCCCCCHHHH | 51.42 | 22210691 | |
287 | Phosphorylation | LLEEIDCTEEEMMVF HHHHCCCCHHHHHHH | 42.56 | 22210691 | |
299 | Phosphorylation | MVFAALQYHINKLSQ HHHHHHHHHHHHHHC | 12.91 | 22210691 | |
316 | Phosphorylation | EVGEPAGTDPGLDDL CCCCCCCCCCCCCHH | 40.92 | 28060719 | |
328 | Phosphorylation | DDLDVALSNLEVKLE CHHHHHHHCCEEEEE | 29.63 | 28060719 | |
334 | Ubiquitination | LSNLEVKLEGSAPTD HHCCEEEEECCCCCH | 12.45 | 24816145 | |
337 | Phosphorylation | LEVKLEGSAPTDVLD CEEEEECCCCCHHHH | 23.00 | 26657352 | |
338 | Ubiquitination | EVKLEGSAPTDVLDS EEEEECCCCCHHHHH | 23.13 | 24816145 | |
340 | Phosphorylation | KLEGSAPTDVLDSLT EEECCCCCHHHHHHC | 38.16 | 29255136 | |
345 | Phosphorylation | APTDVLDSLTTIPEL CCCHHHHHHCCCHHH | 24.37 | 26657352 | |
347 | Phosphorylation | TDVLDSLTTIPELKD CHHHHHHCCCHHHHH | 26.99 | 26074081 | |
348 | Phosphorylation | DVLDSLTTIPELKDH HHHHHHCCCHHHHHH | 39.57 | 26074081 | |
353 | Ubiquitination | LTTIPELKDHLRIFR HCCCHHHHHHEEEEE | 41.25 | 22505724 | |
365 (in isoform 2) | Phosphorylation | - | 38.75 | - | |
369 | Phosphorylation | PRRPRKLTLKGYRQH CCCCCCEECCCCHHE | 29.47 | 23401153 | |
371 | Methylation | RPRKLTLKGYRQHWV CCCCEECCCCHHEEE | 48.97 | 72611923 | |
371 | Ubiquitination | RPRKLTLKGYRQHWV CCCCEECCCCHHEEE | 48.97 | 29967540 | |
373 | Phosphorylation | RKLTLKGYRQHWVVF CCEECCCCHHEEEEE | 12.91 | 23312004 | |
383 | Ubiquitination | HWVVFKETTLSYYKS EEEEEEEEEHHHHCC | 33.36 | 24816145 | |
383 | Phosphorylation | HWVVFKETTLSYYKS EEEEEEEEEHHHHCC | 33.36 | 28060719 | |
384 | Phosphorylation | WVVFKETTLSYYKSQ EEEEEEEEHHHHCCC | 18.13 | 28060719 | |
385 | Ubiquitination | VVFKETTLSYYKSQD EEEEEEEHHHHCCCC | 3.96 | 29967540 | |
386 | Phosphorylation | VFKETTLSYYKSQDE EEEEEEHHHHCCCCC | 25.07 | 28060719 | |
387 | Ubiquitination | FKETTLSYYKSQDEA EEEEEHHHHCCCCCC | 20.30 | 24816145 | |
387 | Phosphorylation | FKETTLSYYKSQDEA EEEEEHHHHCCCCCC | 20.30 | 28060719 | |
388 | Phosphorylation | KETTLSYYKSQDEAP EEEEHHHHCCCCCCC | 10.78 | 28060719 | |
389 | Ubiquitination | ETTLSYYKSQDEAPG EEEHHHHCCCCCCCC | 33.15 | 29967540 | |
390 | Phosphorylation | TTLSYYKSQDEAPGD EEHHHHCCCCCCCCC | 27.09 | 28060719 | |
401 | Ubiquitination | APGDPIQQLNLKGCE CCCCCCCCCCCCCCE | 32.79 | 29967540 | |
405 | Ubiquitination | PIQQLNLKGCEVVPD CCCCCCCCCCEECCC | 61.51 | 29967540 | |
406 | Ubiquitination | IQQLNLKGCEVVPDV CCCCCCCCCEECCCC | 18.91 | 21890473 | |
410 | Ubiquitination | NLKGCEVVPDVNVSG CCCCCEECCCCCCCC | 1.24 | 21890473 | |
415 | Ubiquitination | EVVPDVNVSGQKFCI EECCCCCCCCCEEEE | 7.36 | 22505724 | |
416 | Phosphorylation | VVPDVNVSGQKFCIK ECCCCCCCCCEEEEE | 30.24 | 29970186 | |
419 | Ubiquitination | DVNVSGQKFCIKLLV CCCCCCCEEEEEEEE | 45.81 | 22505724 | |
419 | Acetylation | DVNVSGQKFCIKLLV CCCCCCCEEEEEEEE | 45.81 | 23749302 | |
423 | Ubiquitination | SGQKFCIKLLVPSPE CCCEEEEEEEECCCC | 36.63 | 22505724 | |
428 | Phosphorylation | CIKLLVPSPEGMSEI EEEEEECCCCCCCEE | 28.27 | 28060719 | |
436 | Phosphorylation | PEGMSEIYLRCQDEQ CCCCCEEEHEECCHH | 5.53 | 22817900 | |
445 | Phosphorylation | RCQDEQQYARWMAGC EECCHHHHHHHHHHC | 9.60 | 28176486 | |
478 | Phosphorylation | QAILAFLSLQRTGSG HHHHHHHHCCCCCCC | 18.92 | 24719451 | |
482 | Phosphorylation | AFLSLQRTGSGGPGN HHHHCCCCCCCCCCC | 23.80 | 23401153 | |
484 | Phosphorylation | LSLQRTGSGGPGNHP HHCCCCCCCCCCCCC | 39.71 | 23401153 | |
497 | Phosphorylation | HPHGPDASAEGLNPY CCCCCCCCCCCCCCC | 33.94 | 28464451 | |
504 | Phosphorylation | SAEGLNPYGLVAPRF CCCCCCCCCCCCHHH | 23.24 | 27155012 | |
514 | Ubiquitination | VAPRFQRKFKAKQLT CCHHHHHHHHHHHCC | 40.20 | 24816145 | |
516 | Methylation | PRFQRKFKAKQLTPR HHHHHHHHHHHCCHH | 58.68 | 116253085 | |
518 | Ubiquitination | FQRKFKAKQLTPRIL HHHHHHHHHCCHHHH | 46.56 | 24816145 | |
563 | Ubiquitination | SYVMVRFKGSRKDEI EEEEEEECCCCCHHE | 45.47 | 24816145 | |
567 | Ubiquitination | VRFKGSRKDEILGIA EEECCCCCHHEEEEE | 62.50 | 24816145 | |
586 | Ubiquitination | IRIDLAVGDVVKTWR EEEEEECCHHEEEEE | 19.18 | 21890473 | |
586 (in isoform 2) | Ubiquitination | - | 19.18 | 21890473 | |
590 | Ubiquitination | LAVGDVVKTWRFSNM EECCHHEEEEECCCC | 42.07 | 22817900 | |
590 | Acetylation | LAVGDVVKTWRFSNM EECCHHEEEEECCCC | 42.07 | 26822725 | |
590 (in isoform 1) | Ubiquitination | - | 42.07 | 21890473 | |
591 | Phosphorylation | AVGDVVKTWRFSNMR ECCHHEEEEECCCCC | 15.40 | 28450419 | |
595 | Phosphorylation | VVKTWRFSNMRQWNV HEEEEECCCCCCCCC | 22.57 | 27067055 | |
622 | Phosphorylation | EHINVAFSCVSASCR CCHHHHHHHHHHHHH | 12.13 | - | |
625 | Phosphorylation | NVAFSCVSASCRIVH HHHHHHHHHHHHHHH | 20.84 | - | |
642 | Phosphorylation | IGGYIFLSTRERARG HCCEEEEEHHHHHCC | 18.05 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of URP2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of URP2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of URP2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
612840 | Leukocyte adhesion deficiency 3 (LAD3) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-8 AND TYR-11, AND MASSSPECTROMETRY. | |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-11 AND TYR-504, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-504, AND MASSSPECTROMETRY. |